Objective: The purpose of this study is to explore further a new minimally invasive method in order to expand the surgical options for treating patients with benign prostatic hyperplasia as well as to evaluate the efficacy and safety of endovascular superselective embolization of prostatic arteries in patients with benign prostatic hyperplasia.
Material and methods: The study group included 43 patients with benign prostatic hyperplasia, aged 56 to 90 years. The study carried out in the period from February to December 2019. All patients were determined by the level of prostate-specific antigen, ultrasound scan of the prostate and bladder, uroflowmetry, and used IPSS questionnaire. The physical condition of patients was assessed using the American Society of Anesthesiologists classification.
Results: The technical success of the operation in the form of bilateral embolization of prostatic arteries was achieved in 29 (67.5%) patients. Unolateral embolization of prostatic arteries, due to the complex anatomical structure or atherosclerotic changes, were performed in 14 (32.5%) patients. The observation period was from 3 to 6 months. According to uroflowmetry, the maximum urination rate the average value was 8.5 ± 2.75 ml/s. Six months after the operation the maximum volumetric urine flow rate during urination was on average 24.5 ± 4.20 ml/s.
Conclusion: Our results allow us to evaluate endovascular superselective embolization of prostatic arteries as an effective and safe method of treating lower urinary tract symptoms in men with benign prostatic hyperplasia, and can be introduced as a new promising and minimally invasive method for treating.